image
Dynavax Technologies Corporation DVAX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 12.21
-8.81 %
$ 1.61 B
Market Cap
81.4
P/E
CASH FLOW STATEMENT
101 M OPERATING CASH FLOW
60.35%
Growth Rates
1Year 60.35%
3Years 45.65%
5Years 22.57%
7Years 16.65%
10Years 14.02%
-154 M INVESTING CASH FLOW
51.29%
Growth Rates
1Year 51.29%
3Years -79.69%
5Years -30.43%
7Years -15.75%
10Years -11.60%
1.39 M FINANCING CASH FLOW
-92.90%
Growth Rates
1Year -92.90%
3Years -76.69%
5Years -57.42%
7Years 14.69%
10Years -36.27%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Dynavax Technologies Corporation
image
Net Income -6.39 M
Depreciation & Amortization 7.28 M
Capital Expenditures -4.1 M
Stock-Based Compensation 42.6 M
Change in Working Capital 61.2 M
Others 13.2 M
Free Cash Flow 96.5 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
OPERATING CASH FLOW
Net Income (6.4) 293.2 76.7 (75.2) (152.6) (158.9) (95.2) (112.4) (106.8) (90.7) (66.7) (69.9) (48.6) (57.3) (30.6) (20.8) (60.0) (52.1) (20.6) (16.0) (17.4) (18.0)
Depreciation & Amortization 7.3 6.7 7.0 9.3 21.5 14.5 4.4 2.3 1.4 1.4 1.3 1.2 1.6 2.4 2.8 2.8 0.6 1.5 3.1 3.3 0.6 0.7
Deferred Income Tax (5.2) 61.8 56.7 (10.6) 6.1 (1.5) (0.2) 1.1 2.4 0.9 0.9 1.3 1.2 0.3 (4.1) 3.4 (3.5) (8.9) (1.4) (2.7) (1.8) 0
Stock Based Compensation 42.6 32.9 21.3 13.5 25.5 23.5 14.9 14.1 9.3 6.1 12.3 10.4 5.2 2.4 3.0 3.2 3.5 3.3 1.4 2.7 1.8 0
Other Operating Activities 1.1 (33.4) 1.6 3.7 12.0 2.8 (0.2) 0.6 0.3 0.4 0.9 2.2 1.0 10.4 19.7 (5.7) (3.9) 3.3 17 K 0.3 2.3 1.8
Change in Working Capital 61.2 (298.4) 172.2 (32.9) (33.7) (11.7) (1.3) (12.7) 0.9 8.2 (7.5) 11.0 (7.5) (9.6) (24.4) 65 K 31.2 15.6 (5.4) 5.0 43 K 1.3
Cash From Operations 100.6 62.7 335.5 (92.3) (121.3) (131.3) (77.5) (107.1) (92.6) (73.7) (58.7) (43.8) (47.1) (51.4) (33.6) (17.0) (32.0) (37.2) (22.9) (7.3) (14.4) (14.3)
INVESTING CASH FLOW
Capital Expenditures (4.1) (7.1) (9.5) (11.1) (29.4) (15.2) (0.7) (7.8) (7.0) (1.7) (1.6) (2.9) (1.1) (0.4) (0.4) (4.1) (3.6) (1.1) (0.6) (1.9) (0.1) (0.5)
Other Items (149.8) (308.9) 23.7 (15.5) (13.4) 70.7 (108.0) 94.0 (78.8) 92.3 (49.7) (36.8) (33.5) (50.1) 20.3 34.2 50 K (19.3) (18.1) (44.1) 18.0 (16.8)
Cash From Investing Activities (153.9) (316.0) 14.2 (26.5) (42.8) 55.5 (108.7) 86.2 (85.8) 90.6 (51.4) (39.7) (34.6) (50.5) 19.9 30.1 (3.6) (20.4) (18.7) (46.0) 17.8 (17.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 84 K 0 0 0 0 0 0 0 0 19 K 0 0 0 43 K 0
Total Debt Repaid 0 0 29.6 0 74.2 99.0 0 0 (11.0) 9.6 0 (15.0) 0 0 0 1.2 5.5 0 0.4 0 0 15 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 1.4 19.5 (2.0) 1.0 14.2 71 K 1.9 0.5 1.1 0.2 44.5 2.3 0.1 0.2 19.7 5 K 22 K 17.4 0 (0.1) 100 K 0
Cash From Financing Activities 1.4 19.5 55.8 109.5 154.4 99.1 187.8 0.5 174.0 9.9 125.4 59.0 91.4 87.6 22.1 1.4 35.7 62.9 33.7 46.4 14.9 32.4
CHANGE IN CASH
Net Change In Cash (51.7) (234.2) 404.1 (7.8) (9.9) 22.8 2.3 (20.5) (4.7) 26.4 15.5 (24.3) 9.5 (14.3) 8.6 13.8 0.1 5.4 (7.9) (6.9) 18.3 0.8
FREE CASH FLOW
Free Cash Flow 96.5 55.6 326.1 (103.3) (150.7) (146.5) (78.2) (114.8) (99.5) (75.4) (60.3) (46.7) (48.3) (51.8) (33.9) (21.1) (35.7) (38.4) (23.4) (9.2) (14.5) (14.8)